מאמרים עם הרשאות לגישה ציבורית - Elgene Limלמידע נוסף
לא זמין באתר כלשהו: 1
Imlunestrant with or without abemaciclib in advanced breast cancer
KL Jhaveri, P Neven, ML Casalnuovo, SB Kim, E Tokunaga, P Aftimos, ...
New England Journal of Medicine, 2024
הרשאות: Agence Nationale de la Recherche
זמינים באתר כלשהו: 64
A single-cell and spatially resolved atlas of human breast cancers
SZ Wu, G Al-Eryani, DL Roden, S Junankar, K Harvey, A Andersson, ...
Nature genetics 53 (9), 1334-1347, 2021
הרשאות: US National Institutes of Health, National Health and Medical Research …
XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway
X Chen, D Iliopoulos, Q Zhang, Q Tang, MB Greenblatt, M Hatziapostolou, ...
Nature 508 (7494), 103-107, 2014
הרשאות: US National Institutes of Health
CDK7-dependent transcriptional addiction in triple-negative breast cancer
Y Wang, T Zhang, N Kwiatkowski, BJ Abraham, TI Lee, S Xie, H Yuzugullu, ...
Cell 163 (1), 174-186, 2015
הרשאות: US National Institutes of Health
Targeting androgen receptor in estrogen receptor-negative breast cancer
M Ni, Y Chen, E Lim, H Wimberly, ST Bailey, Y Imai, DL Rimm, XS Liu, ...
Cancer cell 20 (1), 119-131, 2011
הרשאות: US National Institutes of Health
Single-cell analysis reveals diverse stromal subsets associated with immune evasion in triple-negative breast cancer
SZ Wu, DL Roden, C Wang, H Holliday, K Harvey, AS Cazet, KJ Murphy, ...
Biorxiv, 2020.06. 04.135327, 2020
הרשאות: US National Institutes of Health, National Health and Medical Research …
Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
AS Cazet, MN Hui, BL Elsworth, SZ Wu, D Roden, CL Chan, JN Skhinas, ...
Nature communications 9 (1), 2897, 2018
הרשאות: Australian Research Council, National Health and Medical Research Council …
Clinical overview of MDM2/X-targeted therapies
A Burgess, KM Chia, S Haupt, D Thomas, Y Haupt, E Lim
Frontiers in oncology 6, 7, 2016
הרשאות: National Health and Medical Research Council, Australia
Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells
WL Tam, H Lu, J Buikhuisen, BS Soh, E Lim, F Reinhardt, ZJ Wu, JA Krall, ...
Cancer cell 24 (3), 347-364, 2013
הרשאות: US National Institutes of Health, A*Star, Singapore
Stromal cell diversity associated with immune evasion in human triple‐negative breast cancer
SZ Wu, DL Roden, C Wang, H Holliday, K Harvey, AS Cazet, KJ Murphy, ...
The EMBO journal 39 (19), e104063, 2020
הרשאות: US National Institutes of Health, National Health and Medical Research …
CDK12 inhibition reverses de novo and acquired PARP inhibitor resistance in BRCA wild-type and mutated models of triple-negative breast cancer
SF Johnson, C Cruz, AK Greifenberg, S Dust, DG Stover, D Chi, ...
Cell reports 17 (9), 2367-2381, 2016
הרשאות: US National Institutes of Health, National Health and Medical Research …
The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer
TE Hickey, LA Selth, KM Chia, G Laven-Law, HH Milioli, D Roden, ...
Nature medicine 27 (2), 310-320, 2021
הרשאות: US Department of Defense, US National Institutes of Health, National Health …
PARP1-driven poly-ADP-ribosylation regulates BRCA1 function in homologous recombination–mediated DNA repair
Y Hu, SA Petit, SB Ficarro, KJ Toomire, A Xie, E Lim, SA Cao, E Park, ...
Cancer discovery 4 (12), 1430-1447, 2014
הרשאות: US National Institutes of Health, Susan G. Komen
IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
ZN Wee, SMJM Yatim, VK Kohlbauer, M Feng, JY Goh, Y Bao, PL Lee, ...
Nature communications 6 (1), 8746, 2015
הרשאות: A*Star, Singapore
A laminin 511 matrix is regulated by TAZ and functions as the ligand for the α6Bβ1 integrin to sustain breast cancer stem cells
C Chang, HL Goel, H Gao, B Pursell, LD Shultz, DL Greiner, S Ingerpuu, ...
Genes & development 29 (1), 1-6, 2015
הרשאות: US National Institutes of Health
Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling
P Roswall, M Bocci, M Bartoschek, H Li, G Kristiansen, S Jansson, S Lehn, ...
Nature medicine 24 (4), 463-473, 2018
הרשאות: National Health and Medical Research Council, Australia, Swedish Research …
The RasGAP gene, RASAL2, is a tumor and metastasis suppressor
SK McLaughlin, SN Olsen, B Dake, T De Raedt, E Lim, RT Bronson, ...
Cancer cell 24 (3), 365-378, 2013
הרשאות: US National Institutes of Health
A quantitative mass spectrometry-based approach to monitor the dynamics of endogenous chromatin-associated protein complexes
EK Papachristou, K Kishore, AN Holding, K Harvey, TI Roumeliotis, ...
Nature communications 9 (1), 2311, 2018
הרשאות: National Health and Medical Research Council, Australia, Breast Cancer Now …
Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis
M Papanicolaou, AL Parker, M Yam, EC Filipe, SZ Wu, JL Chitty, K Wyllie, ...
Nature communications 13 (1), 4587, 2022
הרשאות: National Health and Medical Research Council, Australia, Susan G. Komen
MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells
Y Wang, YM Lee, L Baitsch, A Huang, Y Xiang, H Tong, A Lako, T Von, ...
Elife 3, e01763, 2014
הרשאות: US National Institutes of Health
המידע על הפרסום ועל הגורמים המממנים נקבע באופן אוטומטי על ידי תוכנת מחשב